Talib WH

No ORCID on file · 1 paper in corpus

lab-animal 2026

Combination of metformin and parthenolide inhibits breast cancer in mice by apoptosis induction and angiogenesis inhibition

Frontiers in immunology ·doi:10.3389/fimmu.2026.1843223

BACKGROUND: Metformin (MET), a widely used antidiabetic agent, and parthenolide (PAR), a natural compound recognized for its anti-inflammatory properties, have both been extensively explored for their anticancer potential. The present study…